Our verdict
Medro advertises compounded semaglutide at a $99 monthly equivalent and tirzepatide at $199 for a three-month introductory term. Its offer describes prepayment, while the refund policy says the first month is charged at intake. Confirm the first debit and renewal before paying.
Main trade-offs
- The $99 and $199 headlines are monthly equivalents billed three months upfront
- Exact regular renewal debits are not clearly published
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Buyers comfortable with a three-month prepaid compounded GLP-1 introduction who want named clinical and pharmacy partners and will verify the renewal charge.
Consider other options if
Anyone who needs month-to-month billing, insurance billing or an exact renewal debit before intake.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Intro: semaglutide $99/mo equivalent ($297 implied upfront), tirzepatide $199/mo equivalent ($597 implied upfront), three months advertised upfront, though policy says first month charged at intake; actual debit and renewal unclear
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- All 50 states claimed; formulation access varies
- LegitScript
- Claimed by provider
Our review in detail
Full assessment
Medro advertises compounded semaglutide at a $99 monthly equivalent and tirzepatide at $199, each for a three-month introductory commitment paid upfront. Multiplying those rates implies $297 and $597 upfront, but its refund policy instead says the first month is charged when intake is completed. The selected first debit is therefore unclear; these totals are arithmetic, not printed checkout prices. The plans renew automatically at regular pricing, but the exact renewal debit is not clearly published. The GLP-1 page promises medication, clinical review, support and delivery at one price for every dose; its FAQ says inclusions vary by product and partner flow. Medro names its medical group and The Pharmacy Hub, but formulation access can vary by state. Confirm the selected plan and renewal amount before completing intake.
What it is
Medro Health Technologies, Inc. runs the website, product catalog and customer flow; it says plainly that it is not a medical provider or a pharmacy. Clinical care comes from Arora Health & Aesthetics, LLC, a medical group with an office in Seattle, led by Dr. Sean Arora, with Dr. Shannon Arora as chief medical officer. The partner pharmacy is The Pharmacy Hub in Miami, Florida, which Medro says is licensed to fill prescriptions in all 50 states. The company's copyright address is in San Francisco, and its terms are governed by Delaware law. Besides weight loss, Medro sells NAD⁺, sermorelin, glutathione and B12 injections, hair-loss treatments, sexual-health medications and estradiol. It's cash-pay only and isn't enrolled with Medicare or Medicaid. By contrast, the Found review covers a service with an insurance route for some visits, alongside compounded and brand-name medication. Users must be 18 or older. The site displays a LegitScript seal (ID 50716646). Its marketing has a few rough edges: one badge repeated across the site reads "Branded medication only" even though every GLP-1 it lists is compounded.
How care works
You start with a free online assessment that takes about three minutes, with no appointment needed. A licensed clinician from the partner group reviews your answers, usually within a day, and decides whether treatment is appropriate; a prescription is never guaranteed. If you're prescribed, your order ships from the partner pharmacy, typically within a day, and free expedited delivery usually takes one to two days. You manage your plan, messages and refills in your Medro account, and the care team handles questions about refills and next steps. Clinical questions go to the licensed partner rather than general support. Medro says it doesn't send sensitive health or intake data to advertising platforms, and it keeps public marketing tracking separate from care flows. If you're not eligible, you won't be prescribed, and Medro may suggest other options.
Costs, billing and cancellation
The GLP-1 page advertises introductory semaglutide at $99 per month equivalent and tirzepatide at $199 per month equivalent, each billed quarterly for a three-month commitment. Quarterly billing is easy to miss, and the Peter MD review shows tirzepatide at $149 for the first month, then $249 a month billed quarterly. Multiplying the displayed rates by three implies $297 and $597 upfront; the page does not separately print those totals. Its refund policy instead says the first month is charged when intake is completed. Ask what will actually be debited at intake because the two public descriptions conflict. It shows semaglutide down from $199 per month, but that struck comparator is not a complete renewal quote. The exact regular renewal debit for either drug is unpublished, and final pricing may vary by medication, dose, supply, availability and clinical review.
The GLP-1 page promises one price at every dose, with medication, online clinical review, support and free expedited delivery. Its FAQ says what is included varies by product and partner flow, so confirm your own quote. The page says the subscription renews automatically at regular pricing; a general FAQ says nothing recurs by default. Its refund policy permits cancellation at least 72 hours before the next billing date and offers no cancellation refund except for medical disqualification.
Medication and evidence
Compounded semaglutide and compounded tirzepatide by weekly injection, each with added glycine and vitamin B12, plus lower-dose microdose versions of both. Medro's disclaimers say compounded medications aren't approved by the FDA and haven't been reviewed for safety, effectiveness or quality, and that it doesn't claim they are the same as brand-name drugs. Adding glycine and B12 hasn't been shown in trials to improve weight loss. The 15% to 20% average weight loss the site cites comes from trials of brand-name GLP-1s, and its before-and-after stories are labeled illustrative. The site mentions brand-name options in general terms, but none is listed with a price. A search of the FDA warning-letter database under Medro, its domain and its clinical partner returned no letters to these companies.
Pros and watch-outs
What we like
- GLP-1 page promises one price at every dose and free shipping
- Prescribing medical group and dispensing pharmacy both named
- Fully online intake with no appointment, usually reviewed within a day
- Full refund if a clinician disqualifies you
- Claims all-state service, subject to product and formulation access; displays a LegitScript seal
Watch-outs
- The $99 and $199 headlines are monthly equivalents billed three months upfront
- Exact regular renewal debits are not clearly published
- No refund on cancellation other than medical disqualification
- Cancellation needs 72 hours' notice before billing
- A site-wide badge says branded only, though its GLP-1s are compounded
Best for
Buyers comfortable with a three-month prepaid compounded GLP-1 introduction who want named clinical and pharmacy partners and will verify the renewal charge.
Who should look elsewhere
Anyone who needs month-to-month billing, insurance billing or an exact renewal debit before intake.
Research relevant to Medro
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
SURMOUNT-5 found 20.2% versus 13.7% average weight loss. What that direct comparison supports, which doses it tested, and why newer formulations need separate evidence.
- “Microdosing” GLP-1 drugs: a trend, not a protocol. What the evidence says
What GLP-1 microdosing means, how it differs from approved maintenance doses, and why daily dose-ranging studies cannot validate a weekly microdose.
How Medro compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Strut Health review and CoreAge Rx review describe what each service publishes about pricing, billing and cancellation.
Strut HealthSeveral telehealth categories with included follow-up care
See Strut Health →
CoreAge RxPublished starting prices with written plan and billing confirmation
See CoreAge Rx →EOS Health
Buyers who want a flat compounded price at any dose, from a company that names its clinical group and pharmacies
See EOS Health →
More GLP-1 telehealth reviews: SkinnyRxClume HealthGreen Cap HealthGaya WellnessNovoCare PharmacyLumiMeds
Research & data
How we assessed this. This review is based on Medro’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does Medro cost?
- Introductory semaglutide is advertised at $99 per month equivalent and tirzepatide at $199, requiring three months upfront: $297 and $597 by arithmetic. A refund policy instead says the first month is charged at intake, so the actual first debit is unclear. Plans auto-renew at regular pricing, whose exact debit is not published.
- Who prescribes and fills Medro prescriptions?
- Clinicians from Arora Health & Aesthetics, a medical group based in Seattle, review intakes and prescribe. Medro names The Pharmacy Hub in Miami as its partner pharmacy; confirm the dispenser for the selected product.
- Do I need a video visit with Medro?
- Medro says no appointment is needed to start. You complete an online assessment and a licensed clinician reviews it, usually within a day.
- Can I get a refund from Medro?
- Only if a clinician disqualifies you for a medical reason. Otherwise canceling doesn't trigger a refund, and the request must arrive at least 72 hours before your billing date.
- Does Medro sell brand-name Wegovy or Zepbound?
- Its GLP-1 menu lists compounded semaglutide and tirzepatide only. The site refers to brand-name options in general terms but doesn't list one with a price.
- Is Medro legit?
- Medro is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: All 50 states claimed; formulation access varies. What it publishes up front: Intro: semaglutide $99/mo equivalent ($297 implied upfront), tirzepatide $199/mo equivalent ($597 implied upfront), three months advertised upfront, though policy says first month charged at intake; actual debit and renewal unclear. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.
